Endocrine, Metabolic & Immune Disorders - Drug Targets

Author(s): Hemanth K. Kandikattu, Sathisha U. Venkateshaiah and Anil Mishra*

DOI: 10.2174/1871530320666200423095700

DownloadDownload PDF Flyer Cite As
Chronic Pancreatitis and the Development of Pancreatic Cancer

Page: [1182 - 1210] Pages: 29

  • * (Excluding Mailing and Handling)

Abstract

Pancreatitis is a fibro-inflammatory disorder of the pancreas that can occur acutely or chronically as a result of the activation of digestive enzymes that damage pancreatic cells, which promotes inflammation. Chronic pancreatitis with persistent fibro-inflammation of the pancreas progresses to pancreatic cancer, which is the fourth leading cause of cancer deaths across the globe. Pancreatic cancer involves cross-talk of inflammatory, proliferative, migratory, and fibrotic mechanisms. In this review, we discuss the role of cytokines in the inflammatory cell storm in pancreatitis and pancreatic cancer and their role in the activation of SDF1α/CXCR4, SOCS3, inflammasome, and NF-κB signaling. The aberrant immune reactions contribute to pathological damage of acinar and ductal cells, and the activation of pancreatic stellate cells to a myofibroblast-like phenotype. We summarize several aspects involved in the promotion of pancreatic cancer by inflammation and include a number of regulatory molecules that inhibit that process.

Keywords: Pancreatitis, pancreatic cancer, cytokines, chemokines, immune cell infiltration, inflammation signaling.